广东
分享至
格隆汇11月4日丨益诺思(688710.SH)公布，拟参与益诺思首发前股东询价转让的股东为上海张江生物医药基地开发有限公司；出让方拟转让股份的总数为4,229,388股，占益诺思总股本的比例为3.00%。
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
